As of November 6, 2026, CytoMed Therapeutics Ltd is a publicly traded company (Nasdaq: GDTC). The largest holder reporting an active stake on Schedule 13D is Choo Chee Kong, at 25.17%. No bankruptcy or receivership appears in its SEC Form 8-K filings. Passive holders reporting on Schedule 13G include mDR LTD (9.98%) (Schedule 13D/A, October 16, 2026).
Is this your company?
About to sign with, pay or invest in CytoMed Therapeutics Ltd? See the free Snapshot first.
Free to see. No signup.
Is CytoMed Therapeutics Ltd a real, registered company?
- CytoMed Therapeutics Ltd files with the SEC under CIK 1873093 (its SEC filings).
- Its shares are listed under the ticker GDTC on Nasdaq (SEC company record).
- Incorporated in U0; business address in 1 Commonwealth Lane, U0, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under CytoMed Therapeutics Ltd in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names mDR LTD (filed 2026-10-23).
Who are CytoMed Therapeutics Ltd's owners and officers?
CytoMed Therapeutics Ltd: business address in 1 Commonwealth Lane, U0; industry Pharmaceutical Preparations (Schedule 13G/A, 2026-10-23).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-10-23 | Mdr LTD | 9.98% |
| Schedule 13D/A, 2026-10-16 | Choo Chee Kong | 25.17% |
| Schedule 13D/A, 2026-10-13 | Choo Chee Kong | 24.92% |
| Schedule 13D/A, 2026-07-24 | Choo Chee Kong | 24.3% |
| Schedule 13D/A, 2025-10-29 | Choo Chee Kong | 22.05% |
Questions about who owns CytoMed Therapeutics Ltd
Who owns CytoMed Therapeutics Ltd?
On this page, 2 holders' latest ownership filings report 5% or more of CytoMed Therapeutics Ltd: Choo Chee Kong (25.17%, Schedule 13D/A, filed 2026-10-16) and Mdr LTD (9.98%, Schedule 13G/A, filed 2026-10-23).
Who are the largest shareholders of CytoMed Therapeutics Ltd?
By the share each holder's latest filing reports, the largest holders of CytoMed Therapeutics Ltd on this page are Choo Chee Kong (25.17%) and Mdr LTD (9.98%).
When did Choo Chee Kong buy into CytoMed Therapeutics Ltd?
The filings give report dates, not purchase dates. The earliest filing from Choo Chee Kong on this page is the Schedule 13D/A, filed 2025-10-29, reporting 22.05%; its latest, Schedule 13D/A filed 2026-10-16, reports 25.17%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 5 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on CytoMed Therapeutics Ltd?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on CytoMed Therapeutics Ltd: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on CytoMed Therapeutics Ltd covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
11 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own CytoMed Therapeutics Ltd shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a director and 10% owner: 630,324 shares (5.3% of shares outstanding) (Form 4/A, 2026-07-24).
- , the chief financial officer: 25,781 shares (0.22% of shares outstanding) (Form 3, 2026-05-15).
- , the chief corporate officer: 25,781 shares (0.22% of shares outstanding) (Form 3, 2026-05-15).
- , a director: 4,000 shares (0.03% of shares outstanding) (Form 3, 2026-05-26).
- , a director: 2,469 shares (0.02% of shares outstanding) (Form 3, 2026-05-15).
Shares outstanding: 11,828,435 as of 2025-12-31, from the company's latest SEC cover page.
How much has CytoMed Therapeutics Ltd raised?
No fundraising or offering filing from CytoMed Therapeutics Ltd is on file with us.
Keep reading
More on CytoMed Therapeutics Ltd and the records around it.
CytoMed Therapeutics Ltd elsewhere on the record
- 5%+ stake filings Oct 2026
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/cytomed-therapeutics